drugset
drugset / Trial / NCT04327934

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

NCT04327934 ↗

Phase 0 Terminated 28 enrolled Yale University National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupOpen-labelBasic science

Summary

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

Timeline

Start
2017-12-01
Primary completion
2022-06-30
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject methyltestosterone Small molecule 5 mg —
Background Ganirelix Protein / enzyme biologic — —

Indications

hypertensive disorder polycystic ovary syndrome